---
title: "Neuroscience of social-cognitive enhancement for well-being and Neural bases of decision processes"
subtitle: "Module 1 - Neuronal Communication"
author: "Raffaele M Mazziotti, PhD"
institute: "University of Florence"
resources:
  - quiz/
  - images/
format:
  revealjs:
    controls: true
    theme: default
    slide-number: true
    logo: images/logo/NEUROFARBA_logo.svg
    css: slide_style.css
    transition: fade
    center: true
    math: mathjax
    chalkboard: 
      buttons: false
    progress: true
    title-slide-attributes:
      data-background-image: images/logo/NEUROFARBA.svg
      data-background-size: 500px
      data-background-position: "center 10%"
      data-state: title-slide
    include-after-body: afterbody.html
      
    mermaid:
      theme: neutral
    
---

## 3. Synaptic Communication

Neurons transmit information to other neurons and target cells using specialized compartments called [Synapses]{.highlight}.
A Synapse is a `specialized junction` where a neuron communicates with another neuron (or another cell).

> IMPORTANT: In synapses, neurons are not physically continous, but there is a gap called [Synaptic Cleft]{.highlight}

::: columns
::: column

::: info-box
Three main components:

- **Presynaptic** compartment (or terminal)
- Synaptic cleft  
- **Postsynaptic** compartment (or spine)
:::


:::
::: column

::: info-box
Synapses allow:

  - Directional signaling  
  - Signal modulation  
  - Integration of multiple inputs
:::

:::
:::

---

## 3. Presynaptic Events

::: columns
::: column

1. [Action potential]{.highlight} arrives at terminal
2. Membrane [depolarization]{.highlight}
3. Opening of [voltage-gated Ca²⁺ channels]{.highlight}
4. Ca²⁺ influx triggers [vesicle]{.highlight} fusion
5. [Neurotransmitter released]{.highlight} into synaptic cleft

:::
::: column
![](images/syn_compartments.png){width="400" fig-align="right"}
:::
:::

## 3. Synaptic Vesicles

::: columns
::: column
- Small `membrane-bound organelles` in the presynaptic terminal  
- **Store neurotransmitters** at high concentration  
- Cluster near [active zones]{.highlight} of the presynaptic membrane  

::: info-box

Key properties:

- Release occurs in discrete, [quantal]{.highlight} events
- The release is mediated by **SNARE proteins**
- Vesicles are [recycled]{.highlight} locally

:::

::: 
::: column

::: info-box
Process:

- SNAREs bring vesicle and presynaptic membranes close together  
- Ca²⁺ influx triggers final fusion step  
- Neurotransmitter released by [exocytosis]{.highlight}

:::

![](images/syn_snare.gif){width="400" fig-align="right"}

::: 
::: 

## 3. Postsynaptic Membrane

::: columns

::: column
Contains neurotransmitter [Receptors](https://en.wikipedia.org/wiki/Receptor_(biochemistry))

::: info-box
Receptors can be of two main `classes`:

- **`Ionotropic` receptors**
  - Ligand-gated ion channels
  - Fast responses

- **`Metabotropic` receptors**
  - G-protein coupled
  - Slower but modulatory (long-lasting response)
:::

:::
::: column

![](images/syn_compartments.png){width="400" fig-align="right"}

:::
:::

##  Postsynaptic Events

::: columns

::: column
Neurotransmitter binding produces graded signals of different types:

- **`EPSP`**: **Excitatory** PostSynaptic Potential
- **`IPSP`**: **Inhibitory** PostSynaptic Potential

::: info-box
[Excitatory synapses]{.highlight}:

- [Depolarize](2_neuron.html#voltage_change) the membrane
- Mediated by Na (or Ca²⁺ in special cases) influx

[Inhibitory synapses]{.highlight}:

- [Hyperpolarize](2_neuron.html#voltage_change) or stabilize membrane potential
- Mediated by Cl⁻ influx

:::
:::
::: column
![](images/syn_transmission.gif){width="500" fig-align="right"}

:::info-box
Neurotransmitter action ends by:

- `Reuptake` into presynaptic terminal
- `Enzymatic degradation` 
:::


:::
:::

##  Neurotransmitters

Neurotransmitters are `chemical messengers` released at synapses  
They transmit signals from a presynaptic neuron to a postsynaptic cell

::: columns
::: column
::: info-box
Each neurotransmitter:

- Is synthesized in the neuron
- Is released in response to activity
- Acts on specific receptors
:::
:::
::: column
::: info-box
Neurotransmitters can be grouped by function:

- **Excitatory**
- **Inhibitory**
- **Modulatory**
:::

:::
:::
> The effect depends on the `receptor`, not only on the neurotransmitter

##  Glutamate - Glu

::: columns
::: column
> Main [excitatory]{.highlight} neurotransmitter in the brain

- Increases neuronal excitability (EPSP)
- Really abbundant in the brain

::: info-box
Acts on:

- Ionotropic receptors
- Metabotropic receptors

:::

:::
::: column
![](images/syn_glu.png){width="350" fig-align="right"}
:::
:::

##  GABA

::: columns
::: column

> Main [inhibitory]{.highlight} neurotransmitter in the brain

- Reduces neuronal excitability (IPSP)
- Essential for network stability

::: info-box
Acts on:

- Ionotropic receptors (fast inhibition)
- Metabotropic receptors (slow inhibition)
:::

:::
::: column
![](images/syn_GABA.png){width="350" fig-align="right"}
:::
:::

##  Acetylcholine - ACh 

::: columns
::: column
> Acts as a `Diffuse Projection System` in the brain. This means that is produced in specific nuclei and projected throughout the brain.
> AKA: `Cholinergic system`

Involved in:

- Muscle contraction
- Vital and Cognitive functions

::: info-box
Acts on:

- Ionotropic receptors
- Metabotropic receptors
:::

:::
::: column
![](images/syn_ach.png){width="250" fig-align="right"}
![](images/syn_diffuse_proj.jpg){width="350" fig-align="right"}
:::
:::

##  Serotonin - 5-Ht {#serotonin}

::: columns
::: column
> Acts as a `Diffuse Projection System` in the brain. This means that is produced in specific nuclei and projected throughout the brain.
> AKA: `Serotoninergic system`

Involved in:

- Mood and Emotional processing
- Vital functions including Sleep and Appetite

::: info-box
Acts on:

- Ionotropic receptors
- Metabotropic receptors
:::

:::
::: column
![](images/syn_5ht.png){width="250" fig-align="right"}
![](images/syn_diffuse_proj.jpg){width="350" fig-align="right"}
:::
:::

##  Dopamine - DA {#dopamine}

::: columns
::: column
> Acts as a `Diffuse Projection System` in the brain. This means that is produced in specific nuclei and projected throughout the brain.
> AKA: `Dopaminergic system`
> 
Involved in:

- Motivation, Learning and Reward
- Movement control

::: info-box
Acts on:

- Metabotropic receptors
:::

:::
::: column
![](images/syn_dop.png){width="250" fig-align="right"}
![](images/syn_diffuse_proj.jpg){width="350" fig-align="right"}
:::
::: 

##  Noradrenaline - NA

::: columns
::: column
> Or Norepinephrine. Acts as a `Diffuse Projection System` in the brain. This means that is produced in specific nuclei and projected throughout the brain.
> AKA: `Noradrenergic System`. 
 
Involved in:

- [Arousal](https://en.wikipedia.org/wiki/Arousal) and Attention
- Stress response

::: info-box
Acts on:

- Metabotropic receptors
:::

:::
::: column
![](images/syn_nor.png){width="250" fig-align="right"}
![](images/syn_diffuse_proj.jpg){width="350" fig-align="right"}
:::
:::

##  Adrenaline

::: columns
::: column
> Or Epinephrine. Less abundant in the Central Nervous System than other neurotransmitters. More Peripheral.

Involved in:

- [Arousal](https://en.wikipedia.org/wiki/Arousal) and [Autonomic](https://en.wikipedia.org/wiki/Autonomic_nervous_system) regulation
- Stress response

::: info-box
Acts on:

- Metabotropic receptors
:::

:::
::: column
![](images/syn_adre.png){width="350" fig-align="right"}
:::
:::

##  Other Signaling Molecules

In addition to classical neurotransmitters, neurons use other chemical signals.  
These molecules often act as modulators rather than fast transmitters

::: columns
::: column
::: info-box
Neuropeptides

- **Endorphins**
  - Pain, Reward, Stress regulation ...

- **Oxytocin**
  - Social, Maternal behavior ...

- **Substance P**
  - Pain, Inflammatory responses ...
:::

:::
::: column

::: info-box
Other Signaling Systems

- **Endocannabinoids**
  - Appetite, mood, and memory, [Retrograde signaling](https://en.wikipedia.org/wiki/Retrograde_signaling) ....

- **Nitric Oxide (NO)**
  - Retrograde and Short-range signaling, Blood flow regulation ...
:::

:::
:::

##  Receptors

Neurotransmitters act by binding to `receptors` on the postsynaptic membrane  
Receptors determine the `speed and effect` of synaptic transmission

::: columns
::: column

::: info-box
**Ionotropic** Receptors

- `Ligand`-gated ion channels
- Neurotransmitter `binding` directly opens the channel
- Produce `fast` responses (milliseconds)
:::

:::
::: column

::: info-box
**Metabotropic** Receptors

- Do not form ion channels
- Coupled to intracellular [signaling pathways](https://en.wikipedia.org/wiki/Signal_transduction)
- Neurotransmitter binding activates `G-proteins`
- Effects are `slower` but longer-lasting
:::

:::
:::

##  Glutamate Ionotropic Receptors

::: columns
::: column
Glutamate activates multiple ionotropic receptors, including:

- **`AMPA` receptors**
  - Fast `excitatory` transmission
  - Allow `Na⁺` influx
  - Main mediator of [rapid excitation]{.highlight}

- **`NMDA` receptors**
  - Slower and Long-lasting kinetics
  - Permeable to `Ca²⁺`
  - Involved in [synaptic plasticity]{.highlight}

::: 
::: column
![](images/syn_glu_iono.jpg){width="450" fig-align="right"}
:::
:::

##  GABA Ionotropic Receptors

::: columns
::: column

**GABA-A receptors**

  - Ionotropic `inhibitory` receptors
  - Allow `Cl⁻` influx
  - Reduce neuronal excitability

Provide [fast inhibition]{.highlight} in neural circuits

:::

::: column

![](images/syn_GABA_recep.png){width="450" fig-align="right"}
:::

:::

##  Metabotropic Receptors

- Do not form ion channels
- Coupled to intracellular [singaling pathways](https://en.wikipedia.org/wiki/Signal_transduction)
- Neurotransmitter binding activates `G-proteins`
- Effects are `slower` but longer-lasting

> `Signaling Pathway`: chain of intracellular events where molecules relay messages from outside the cell to trigger specific internal responses like growth, division, or death

##  **Metabotropic glutamate receptors (mGluRs)**

::: columns
::: column
  - Modulate synaptic transmission
  - Regulate ion channel activity indirectly
  - Influence plasticity and excitability

> Similar mechanisms apply to many [modulatory systems]{data-tooltip="AKA: diffuse projection system" .term} systems, such as [dopamine](#dopamine) and [serotonin](#serotonin)

:::info-box
[Neuromodulation]{.highlight} is the process by which a neurotransmitter does not directly trigger a fast electrical signal, but instead changes how a neuron or a network responds to external inputs.
:::

:::
::: column

![](images/syn_metabotropic.png){width="300" fig-align="right"}

:::
:::

##  Position of the Synapse

Also the position of a synapse along a neuron matters, because neurons are not electrically uniform cables. Where a signal arrives strongly shapes what it can do.

:::columns
::: column

:::info-box 
- **Axo-dendritic**
  - Axon contacts a dendrite (Most common type)
  - Often excitatory
:::
:::info-box
- **Axo-somatic**
  - Axon contacts the cell body
  - Strong influence on spike generation
:::
:::
::: column

:::info-box
- **Axo-axonic**
  - Axon contacts another axon
  - Modulates neurotransmitter release
:::
![](images/syn_syn_type.jpg){width="500" fig-align="right"}


:::
:::

##  Neurotransmitter Clearance

After release, neurotransmitters must be removed from the synaptic cleft  
This ensures that synaptic signals are brief and precisely controlled

- [Reuptake]{.highlight}
  - Neurotransmitter is `transported back` into the presynaptic terminal
  - Mediated by specific `membrane transporters`
  - Allows `recycling` of neurotransmitter molecules

- [Enzymatic Degradation]{.highlight}
  - Neurotransmitter is broken down by `enzymes` in the synaptic cleft
  - Prevents prolonged receptor activation

##  Drugs and Neurotransmitter Clearance

Many drugs act by altering how neurotransmitters are removed from the synaptic cleft  
By changing clearance, drugs modify the strength and duration of synaptic signaling.

:::columns
:::column

:::info-box
Selective Serotonin Reuptake Inhibitors (`SSRIs`)

  - Block serotonin reuptake transporters
  - Increase serotonin availability at synapses

Used to treat:

- Depression
- Anxiety disorders

Effects develop slowly due to circuit-level adaptations
:::

:::
:::column
:::info-box
`Cocaine`

- Blocks reuptake of:
  - Dopamine
  - Norepinephrine
  - Serotonin

Results in:

- Strong increase in synaptic signaling
- Enhanced `reward` and `arousal`
- High addictive potential
:::

:::
:::

##  Self-check

```{=html}
<div style="display: flex; justify-content: center;">
  <iframe src="quiz/quiz_3_synapse.html"
          style="
            width: 90vw;
            max-width: 900px;
            height: 80vh;
            border: none;
            border-radius: 16px;
          ">
  </iframe>
</div>
```


